PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: INTRODUCTION • Market outline PART 05: MARKET LANDSCAPE • Market overview • Market size and forecast • Five forces analysis PART 06: MARKET SEGMENTATION BY ROUTE OF ADMINISTRATION (ROA) • Injectable • Oral • Topical PART 07: REGIONAL LANDSCAPE • Regional comparison • Anti-aging drugs market in Americas • Anti-aging drugs market in EMEA • Anti-aging drugs market in APAC • Key leading countries • Market opportunity PART 08: DECISION FRAMEWORK PART 09: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 10: MARKET TRENDS PART 11: VENDOR LANDSCAPE • Competitive landscape PART 12: KEY VENDOR ANALYSIS • Allergan • Galderma • Merz Pharma • Sanofi • Other prominent vendors PART 13: APPENDIX • List of abbreviations List of Exhibits Exhibit 01: Major aging effects on different parts of the body Exhibit 02: Factors contributing to early onset of aging Exhibit 03: Global anti-aging drugs market: Snapshot Exhibit 04: Global anti-aging drugs market 2016-2021 ($ millions) Exhibit 05: Five forces analysis Exhibit 06: Decisive factors for choice of RoA Exhibit 07: Major RoA for drug intake Exhibit 08: Global anti-aging drugs market by RoA 2016 ($ millions) Exhibit 09: Global anti-aging drugs market by RoA 2016-2021 ($ millions) Exhibit 10: Types of injections Exhibit 11: Adverse effects of injectable drugs Exhibit 12: Types of dermal fillers Exhibit 13: Some common dermal filllers Exhibit 14: Global anti-aging injectable drugs market 2016-2021 ($ millions) Exhibit 15: Advantages and disadvantages of oral RoA Exhibit 16: Global anti-aging oral drugs market 2016-2021 ($ millions) Exhibit 17: Global anti-aging topical drugs market 2016-2021 ($ millions) Exhibit 18: Regional landscape Exhibit 19: Regional comparison Exhibit 20: Anti-aging drugs market in Americas 2016-2021 (% share) Exhibit 21: Anti-aging drugs market in Americas – Year over year growth Exhibit 22: Economic and healthcare snapshot of Europe 2014 Exhibit 23: Anti-aging drugs market in EMEA 2016-2021 (& share) Exhibit 24: Anti-aging drugs market in EMEA – Year over year growth Exhibit 25: Anti-aging drugs market in APAC 2016-2021 (% share) Exhibit 26: Anti-aging drugs market in APAC – Year over year growth Exhibit 27: Key leading countries Exhibit 28: Demographic and economic snapshot of India and China Exhibit 29: World population by age group: 2015-2050 Exhibit 30: Percentage distribution of global population aged 65 years and above by region, 2015-2050 Exhibit 31: Percentage of population aged 60 and above by region, 2015-2050 Exhibit 32: Global average cost of dermal fillers ($) Exhibit 33: Side effects associated with common anti-aging techniques Exhibit 34: Competitive structure analysis of global anti-aging drugs market 2016 Exhibit 35: Allergan: Key highlights Exhibit 36: Allergan: Strength assessment Exhibit 37: Allergan: Strategy assessment Exhibit 38: Allergan: Opportunity assessment Exhibit 39: Galderma: Key highlights Exhibit 40: Galderma: Strength assessment Exhibit 41: Galderma: Strategy assessment Exhibit 42: Galderma: Opportunity assessment Exhibit 43: Merz Pharma: Key highlights Exhibit 44: Merz Pharma: Strength assessment Exhibit 45: Merz Pharma: Strategy assessment Exhibit 46: Merz Pharma: Opportunity assessment Exhibit 47: Key highlights Exhibit 48: Sanofi: Strength assessment Exhibit 49: Sanofi: Strategy assessment Exhibit 50: Sanofi: Opportunity assessment

Allergan, Galderma, Merz Pharma, and Sanofi, Canbex Therapeutics, Daewoong Pharmaceutical, MMJ PhytoTech, Revitacare, SciVision Biotech, Sun Pharmaceuticals, Suneva Medical, Syneron, and Valeant Pharmaceuticals.